Purchases and Sales Made in Q2 2023 in Ovid Therapeutics Inc. (OVID)
This table provides information about the institutional ownership of Ovid Therapeutics Inc. (OVID) during Q2 2023. The information is specifically focused on institutions that hold shares of Ovid Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 09, 2023
Q2 2023
|
Dcf Advisers, LLC
Greenwich, CT |
SELL
|
- |
-3.5K- 5.13% |
$8.86K - $13.6K
|
64.8K
$27.2K
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-5.9K- 4.89% |
$14.9K - $23K
|
115K
$48.2K
|
|
|
Aug 11, 2023
Q2 2023
|
Tejara Capital LTD
London, X0 |
SELL
|
- |
-6.2K- 5.22% |
$15.7K - $24.1K
|
113K
$47.3K
|
|
|
Aug 14, 2023
Q2 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-15.4K- 55.95% |
$38.9K - $59.9K
|
12.1K
$5.09K
|
|
|
Aug 14, 2023
Q2 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-26.4K- 3.19% |
$66.9K - $103K
|
801K
$336K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-27K- 46.73% |
$68.4K - $105K
|
30.8K
$12.9K
|
|
|
Nov 15, 2023
Q2 2023
|
Tls Advisors LLC
Miami, FL |
SELL
|
- |
-60.7K- 4.4% |
$153K - $236K
|
1.32M
$554K
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-147K- 89.64% |
$371K - $571K
|
17K
$7.12K
|
|
|
Aug 14, 2023
Q2 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-232K- 68.37% |
$587K - $902K
|
107K
$45.1K
|
|
|
Aug 11, 2023
Q2 2023
|
Rubric Capital Management LP
New York, NY |
SELL
|
- |
-1.56M- 22.21% |
$3.93M - $6.05M
|
5.45M
$2.29M
|